A 5-year follow-up study of generalized anxiety disorder and panic disorder

Journal of Nervous and Mental Disease

Volumn 187, Issue 1, 1999, Pages 3-9

  Woodman, Catherine L ^a,b   Noyes Jr , Russell ^a   Black, Donald W ^a   Schlosser, Steve ^a   Yagla, Stephen J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PANIC; RATING SCALE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGE OF ONSET; ANXIETY DISORDERS; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MARITAL STATUS; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PANIC DISORDER; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 0032940629     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199901000-00002     Document Type: Article

References (24)

1. Anderson DJ, Noyes R, Crowe RR (1984) A comparison of panic disorder and generalized anxiety disorder. Am J Psychiatry 141:572-575.
2. Angst J, Vollrath M (1991) The natural history of anxiety disorders. Acta Psychiatr Scand 84:446-452.
3. Ballenger JC, McDonald S, Noyes R, Rickels K, Sussman N, Woods S, Patin J, Surger J (1991) The first double-blind placebo-controlled trial of abecarnil (ZK 112-119), a partial benzodiazepine agonist, in generalized anxiety disorder. Psychopharmacol Bull 27:171-180.
4. Black DW, Wesner R, Bowers W, Gabel J (1993) A comparison of fluvoxamine, cognitive behavior, and placebo in treatment of panic disorder. Arch Gen Psychiatry 50:44-50.
5. Hamilton M (1959) The assessment of anxiety status by rating. Br J Med Psychol 32:50-55.
6. Hoehn-Saric R, Hazlett RL, McLeod DR (1993) Generalized anxiety disorder with early and late onset of anxiety symptoms. Compr Psychiatry 34:291-298.
7. Mancuso DM, Townsend MH, Mercante DE (1993) Long-term follow-up of generalized anxiety disorder. Compr Psychiatry 34:441-446.
8. Marks IM, Mathews AM (1979) Brief standard self-rating for phobic patients. Behav Res Ther 17:263-267.
9. Meyer TJ, Miller ML, Metzger RL, Borkovec TD (1990) Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 28:487-495.
10. National Institute of Mental Health (1985) Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:1-78.
11. Noyes R (1988) The natural history of anxiety disorders. In M Roth, GD Burrows, and R Noyes (Eds) Handbook of anxiety, vol. 1., Amsterdam, Elsevier Science Publishers.
12. Noyes R (1992) The outcome of panic disorder as influenced by illness variables and coexisting syndromes. In GD Burrows, M Roth, R Noyes (Eds), Handbook of anxiety (Vol 5). Amsterdam: Elsevier Science Publishers.
13. Noyes R, Clancy J, Hoenk PR (1978) Anxiety neurosis and physical illness. Compr Psychiatry 19:407-413.
14. Noyes R, Woodman C, Garvey, M, Cook B, Sueltzer M, Anderson D (1992) Generalized anxiety disorder versus panic disorder: Distinguishing characteristics and patterns of comorbidity. J Nerv Ment Dis 180:369-379.
15. Rickels K, Case WG, Downing RW, Fridman R (1986) One-year follow-up of anxious patients treated with diazepam. J Clin Psychopharmacol 6:32-36.
16. Rickels K, Schweizer E (1990) The clinical course and long-term management of generalized anxiety disorder. J Clin Psychopharmacol 10(Suppl 3):101S-110S.
17. Shapiro RW, Keller MB (1981) Initial 6-month follow-up of patients with major depressive disorder: A preliminary report from the NIMH collaborative study of the psychobiology of depression. J Affective Disord 3:205-220.
18. Sheehan DV (1986) The anxiety disease. New York: Bantam Books.
19. Smith GR, Monson RA, Ray DC (1986) Patients with multiple unexplained symptoms: Their characteristics, functional health, and health care utilization. Arch Int Med 146:69-72.
20. Spitzer RL, Williams JB, Gibbon M, First M (1990) Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press.
21. Uhlenhuth ED, Balter MB, Mellinger GD, Cissen IH, Clinthorne J (1983): Symptom checklist syndromes in the general population: correlations with psychotherapeutic drug use. Arch Gen Psychiatry 40:1167-1173.
22. Wittchen HU, Zhao S, Kessler RC, Eaton WW (1994) DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatr 51:355-364.
23. Woodman CL, Noyes R, Ballenger JC, Lydiard RB, Sievers G, Mihalko D (1994) Predictors of response to alprazolam and placebo in patients with panic disorder. J Affective Disord 30:5-13.
24. Yonkers KA, Warshaw MG, Massion AO, Keller MB (1996) Phenomenology and course of generalized anxiety disorder. Br J Psychiatry 168:308-313